Navigation Links
Quantum Materials Corporation Announces Non-Heavy Metal (Cadmium-Free) Tetrapod Quantum Dots
Date:2/12/2013

CARSON CITY, Nev., Feb. 12, 2013 /PRNewswire/ -- Quantum Materials Corporation (QMC) (OTCQB:QTMM) announces a new class of cadmium-free, non-REE, non-heavy metal tetrapod quantum dots (NHM-TPQD) developed to meet worldwide concerns regarding nanoparticle biocompatibility and sustainability.

(Logo:  http://photos.prnewswire.com/prnh/20121120/DA16554LOGO)

QMC can produce industrial scale quantities of NHM-TPQD using proprietary continuous flow chemistry processes with over 90% tetrapod shape and size uniformity, unmatched in the industry. The new availability of a reliable supply of high quantities of uniform and low cost non-heavy metal tetrapod quantum dots will spur development of products and applications in next-generation displays, sensors, biomedical research, diagnostics and drug delivery, security and conductive inks, solid-state lighting (SSL) and photovoltaic solar cells, currently under development by QMC subsidiary Solterra Renewable Technologies.

Quantum dots in biomedical imaging are unique fluorescent probes with advantages over dyes and other fluorophores. QMC has made improvements in quantum dot brightness (high quantum yield), photostability for longer sample lifetime, high uniformity, narrow band, wide spectrum, and tunable emission spectrum. According to a 2012 market research report by Global Industry Analyst, Inc., the total market for Global BioImaging Technologies in 2017 is forecast to reach $34.7 billion.

In 2011, Quantum Materials and NanoAxis LLC pioneered a Joint Alliance to develop Tetrapod Quantum Dot based Cancer diagnostic kits and theranostic applications including Alzheimer's, Type 1 and Type 2 Diabetes, Breast Cancer and Major Depression.

Quantum Materials CEO and Founder, Mr. Stephen Squires commented, "While our cadmium-based high-brightness tetrapod quantum dots are unparalleled in photovoltaic solar cell applications and especially for commercializing high value, small quantity in vitro research and lab applications, our non-heavy metal tetrapod quantum dot answers the world's ecological and in vivo human toxicological concerns for mass-produced QD in the biotech and other fields of science."

Quantum Materials Corporation is poised to become the world's largest manufacturer of quantum dots by scaling production to multiple kilograms per day in 2013. QMC's production is not subject to any other manufacturer's patents and QMC is free to joint venture and to license its technology.

Mr. Squires is speaking at the CHI Emerging Diagnostics Partnering Forum in San Francisco this week on quantum dot applications in the next generation of diagnostic assays, multiplexed drug delivery platforms and handheld POC devices. Quantum Materials Corporation is then exhibiting at the CHI Molecular Med Tri-Conference on February 13-14, Booth 622.

About Quantum Materials Corporation and its subsidiary, Solterra Renewable Technologies

QUANTUM MATERIALS CORPORATION, INC. has a steadfast vision that advanced technology is the solution to the most challenging of global issues. Quantum Materials Corporation is devoted to the deployment of technologies to invigorate the development of disruptive solutions through cost reduction and moving laboratory discovery to commercialization with volume manufacturing methods to establish a growing line of innovative high performance products.

(http://www.quantummaterials.us)

SOLTERRA RENEWABLE TECHNOLOGIES, INC., a wholly-owned subsidiary of Quantum Materials Corporation, is developing thin-film quantum dot solar cell technology.

(http://www.solterrasolarcells.com)

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at http://www.sec.gov/ or from our website. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

Contact: Art Lamstein
Quantum Materials Corp.
Director of Marketing  
artlamstein@qmcdots.com


'/>"/>
SOURCE Quantum Materials Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Invisible tool enables new quantum experiments
2. Using single quantum dots to probe nanowires
3. Revolutionary Tetrapod Quantum Dot Synthesis US Patent Granted
4. Lava dots: Rice makes hollow, soft-shelled quantum dots
5. Scientists demonstrate high-efficiency quantum dot solar cells
6. Single-atom writer a landmark for quantum computing
7. The quantum world only partially melts
8. Imprisoned molecules quantum rattle in their cages
9. Nature: Electronic read-out of quantum bits
10. Quantum physics: New insights into the remote control of quantum systems
11. UK research paves way to a scalable device for quantum information processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... ... of the latest paper by its Science Editor, Dr. Elisabeth Bik, in the ... Medische Microbiologie). Dr. Bik joined uBiome in October 2016 from her previous position ...
(Date:1/18/2017)... 18, 2017 Shareholder rights law firm Johnson ... the board members of CoLucid Pharmaceuticals, Inc. (NASDAQ: ... with the proposed sale of the Company to Eli ... develops small molecules for the acute treatment of migraines. ... had signed a definitive merger agreement with Eli Lilly. ...
(Date:1/18/2017)... , Jan. 18, 2017  Caris Life Sciences, ... Lustgarten Foundation, the largest private funder of pancreatic ... trial evaluating the impact of immunotherapy in the ... trial enrollment services to identify potential trial candidates ... between treating physicians and study investigators. The Lustgarten ...
(Date:1/18/2017)... , Jan. 18, 2017  Market Research Future published a half-cooked ... is expected to grow at a CAGR of 12% during the ... ... due to the abnormal cell division without any control. These abnormal ... to them. These cancer cells can spread to other parts of ...
Breaking Biology Technology:
(Date:1/4/2017)... LAS VEGAS , Jan. 4, 2017  For the thousands of ... , a global leader in connected health and biometric measurement devices and ... pressure monitors. On display in A&D Medical,s special CES ... monitors represent the ongoing expansion of the company,s WellnessConnected product ... ...
(Date:12/20/2016)... LONDON , Dec. 20, 2016 ... car sharing, rental and leasing is stoking significant ... of radio frequency technology, Bluetooth low energy (BLE), ... emerge as the next wave of wireless technologies ... vehicle access system to advanced access systems opens ...
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
Breaking Biology News(10 mins):